Publication Date
In 2024 | 0 |
Since 2023 | 0 |
Since 2020 (last 5 years) | 0 |
Since 2015 (last 10 years) | 0 |
Since 2005 (last 20 years) | 33 |
Descriptor
Adolescents | 49 |
Attention Deficit Disorders | 49 |
Drug Therapy | 49 |
Children | 38 |
Hyperactivity | 38 |
Symptoms (Individual… | 21 |
Outcomes of Treatment | 17 |
Intervention | 11 |
Comparative Analysis | 10 |
Stimulants | 10 |
Age Differences | 7 |
More ▼ |
Source
Author
Publication Type
Education Level
Elementary Secondary Education | 1 |
High Schools | 1 |
Middle Schools | 1 |
Audience
Teachers | 2 |
Parents | 1 |
Practitioners | 1 |
Researchers | 1 |
Location
Canada | 2 |
United States | 2 |
Australia | 1 |
Brazil | 1 |
Taiwan (Taipei) | 1 |
Texas | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Wechsler Intelligence Scale… | 2 |
Aberrant Behavior Checklist | 1 |
Conners Rating Scales | 1 |
Continuous Performance Test | 1 |
What Works Clearinghouse Rating
Fleary, Sasha A.; Heffer, Robert W.; McKyer, E. Lisako J. – Journal of Adolescence, 2011
The primary purpose of this study was to examine the extent to which two of the three sources of risk-taking--dispositional and ecological--in adolescence and demographic variables were related to Ritalin, tranquilizer and narcotics misuse. The secondary aim of this study was to distinguish subgroups of Ritalin, tranquilizer, and narcotics…
Descriptors: Substance Abuse, Narcotics, Prevention, Attention Deficit Disorders
Kubiszyn, Thomas; Mire, Sarah; Dutt, Sonia; Papathopoulos, Katina; Burridge, Andrea Backsheider – School Psychology Quarterly, 2012
Some side effects (SEs) of increasingly prescribed psychotropic medications can impact student performance in school. SE risk varies, even among drugs from the same class (e.g., antidepressants). Knowing which SEs occur significantly more often than others may enable school psychologists to enhance collaborative risk-benefit analysis, medication…
Descriptors: Evidence, Narcotics, Incidence, School Psychologists
Hwang, Shoou-Lian; Gau, Susan Shur-Fen; Hsu, Wen-Yau; Wu, Yu-Yu – Journal of Child Psychology and Psychiatry, 2010
Background: The underlying mechanism of time perception deficit in long time intervals in attention-deficit/hyperactivity disorder (ADHD) is still unclear. This study used the time reproduction dual task to explore the role of the attentional resource in time perception deficits among children and adolescents with ADHD. Methods: Participants…
Descriptors: Intelligence, Intervals, Schizophrenia, Attention Deficit Hyperactivity Disorder
Spencer, Thomas J.; Sallee, F. Randy; Gilbert, Donald L.; Dunn, David W.; McCracken, James T.; Coffey, Barbara J.; Budman, Cathy L.; Ricardi, Randall K.; Leonard, Henrietta L.; Allen, Albert J.; Milton, Denai R.; Feldman, Peter D.; Kelsey, Douglas K.; Geller, Daniel A.; Linder, Steven L.; Lewis, Donald W.; Winner, Paul K.; Kurlan, Roger M.; Mintz, Mark – Journal of Attention Disorders, 2008
Objective: This study examines changes in severity of tics and ADHD during atomoxetine treatment in ADHD patients with Tourette syndrome (TS). Method: Subjects (7-17 years old) with ADHD ("Diagnostic and Statistical Manual of Mental Disorders, DSM-IV") and TS were randomly assigned to double-blind treatment with placebo (n = 56) or atomoxetine…
Descriptors: Metabolism, Attention Deficit Disorders, Patients, Severity (of Disability)
Marcus, Steven C.; Wan, George J.; Zhang, Huabin F.; Olfson, Mark – Journal of Attention Disorders, 2008
Objective: To assess risk factors for injury among children and adolescents treated with stimulants for ADHD. Method: An analysis was performed of pharmacy and service claims data from 2000-2003 California Medicaid (Medi-Cal) focusing on children and adolescents ages 6 to 17 years who initiated stimulant therapy for ADHD. Bivariate and…
Descriptors: Stimulants, Injuries, Risk, Adolescents
Greenhill, Laurence L.; Newcorn, Jeffrey H.; Gao, Haitao; Feldman, Peter D. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: To compare the effects of two different methods for initiating atomoxetine in terms of the incidence of early adverse events. Method: Data on atomoxetine treatment-emergent adverse events in youths, ages 6 to 18 years, were analyzed from five randomized, double-blind, placebo-controlled, acute-phase studies. Two studies involve…
Descriptors: Patients, Drug Therapy, Symptoms (Individual Disorders), Sleep
Findling, Robert L.; Short, Elizabeth J.; McNamara, Nora K.; Demeter, Christine A.; Stansbrey, Robert J.; Gracious, Barbara L.; Whipkey, Resaca; Manos, Michael J.; Calabrese, Joseph R. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
The short-term efficacy of methylphenidate in the treatment of youths aged 5 to 17 years with bipolar disorder (BD) and comorbid attention deficit/hyperactivity disorder (ADHD) was investigated. The trial observation showed that euthymic youths with BD and ADHD might benefit from short-term concomitant treatment with methylphenidate.
Descriptors: Hyperactivity, Attention Deficit Disorders, Depression (Psychology), Children
Walker, Karen – Education Partnerships, Inc., 2009
What does the research indicate are the effects of medicating or not medicating adolescents with ADHD? Many parents and health care providers are rethinking and questioning the long-term effects of medication on children. Whether or not to medicate adolescents with ADHD is a conundrum that many parents face. Some parents believe their child will…
Descriptors: Adolescents, Developmental Delays, Drug Abuse, Attention Deficit Disorders
Kratochvil, Christopher J.; Michelson, David; Newcorn, Jeffrey H.; Weiss, Margaret D.; Busner, Joan; Moore, Rodney J.; Ruff, Dustin D.; Ramsey, Janet; Dickson, Ruth; Turgay, Atilla; Saylor, Keith E.; Luber, Stephen; Vaughan, Brigette; Allen, Albert J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: To assess the utility and tolerability of higher than standard atomoxetine doses to treat attention-deficit/hyperactivity disorder (ADHD). Method: Two randomized, double-blind trials of atomoxetine nonresponders ages 6 to 16 years were conducted comparing continued treatment with same-dose atomoxetine to treatment using greater than…
Descriptors: Hyperactivity, Attention Deficit Disorders, Rating Scales, Patients
Barkley, Russell A. – School Psychology Review, 2007
In this article, the author considers some issues concerning future research into school-based assessment and management of attention deficit hyperactivity disorder (ADHD). He focuses on a few issues of some relevance to school interventions for children and teens with ADHD. He features three articles that found that less intensive interventions…
Descriptors: Hyperactivity, Attention Deficit Disorders, Intervention, Children
Jones, Jana E.; Watson, Ryann; Sheth, Raj; Caplan, Rochelle; Koehn, Monica; Seidenberg, Michael; Hermann, Bruce – Developmental Medicine & Child Neurology, 2007
The aim of this study was to characterize the distribution, timing, and risk factors for psychiatric comorbidity in children with recent onset epilepsy. Children aged 8 to 18 years with recent onset epilepsy (less than 1 year in duration) of idiopathic etiology (n=53) and a healthy comparison group (n=50) underwent a structured psychiatric…
Descriptors: Incidence, Neurological Organization, Drug Therapy, At Risk Persons
Michelson, David; Read, Holly A.; Ruff, Dustin D.; Witcher, Jennifer; Zhang, Shuyu; McCracken, James – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Background: Atomoxetine, a selective norepinephrine reuptake inhibitor effective in the treatment of attention-deficit/hyperactivity disorder (ADHD), is metabolized through the cytochrome P-450 2D6 (CYP2D6) enzyme pathway, which is genetically polymorphic in humans. Variations in plasma atomoxetine exposures can occur because of genetic variation…
Descriptors: Economically Disadvantaged, Metabolism, Adolescents, Hyperactivity
Hughes, Carroll W.; Emslie, Graham J.; Crismon, M. Lynn; Posner, Kelly; Birmaher, Boris; Ryan, Neal; Jensen, Peter; Curry, John; Vitiello, Benedetto; Lopez, Molly; Shon, Steve P.; Pliszka, Steven R.; Trivedi, Madhukar H. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: To revise and update consensus guidelines for medication treatment algorithms for childhood major depressive disorder based on new scientific evidence and expert clinical consensus when evidence is lacking. Method: A consensus conference was held January 13-14, 2005, that included academic clinicians and researchers, practicing…
Descriptors: Guidelines, Psychosis, Depression (Psychology), Clinical Experience
Pedersen, Scott J.; Heath, Matthew; Surburg, Paul R. – Journal of Attention Disorders, 2007
Objective: Children with ADHD have been labeled as "uncoordinated" and "inefficient movers"; however, a paucity of research has systematically examined "stimulant-free" motor processing in this population. Method: In the present investigation, the authors employ a cross-lateral integration task to assess the…
Descriptors: Reaction Time, Attention Deficit Disorders, Males, Hyperactivity
Hervey-Jumper, Heather; Douyon, Karl; Falcone, Tatiana; Franco, Kathleen N. – Journal of Attention Disorders, 2008
Objective: This literature review describes evaluation and treatment of minority youth with ADHD. Method: A search of databases for reports of ADHD in minority children was conducted. Results: Interpretation of behavior varies among parents, as does their trust in health care providers and school personnel. Parents desire to avoid stigmatization…
Descriptors: Stimulants, Trust (Psychology), Minority Group Children, Drug Therapy